Meng Y - Search Results

1

NUAK1-Mediated Phosphorylation of NADK Mitigates ROS Accumulation to Promote Osimertinib Resistance in Non-Small Cell Lung Carcinoma.

Lin W, Wang N, Wu S, Diao M, Huang Q, Li K, Mei P, Wang X, Liao Y, Meng Y. Lin W, et al. Among authors: meng y. Cancer Res. 2024 Aug 19. doi: 10.1158/0008-5472.CAN-24-0249. Online ahead of print. Cancer Res. 2024. PMID: 39159134

2

Bazedoxifene-induced ROS promote mitochondrial dysfunction and enhance osimertinib sensitivity by inhibiting the p-STAT3/SOCS3 and KEAP1/NRF2 pathways in non-small cell lung cancer.

Meng Y, Lin W, Wang N, Wei X, Huang Q, Liao Y. Meng Y, et al. Free Radic Biol Med. 2023 Feb 20;196:65-80. doi: 10.1016/j.freeradbiomed.2023.01.004. Epub 2023 Jan 13. Free Radic Biol Med. 2023. PMID: 36646328

3

USP7-mediated ERβ stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma.

Meng Y, Lin W, Wang N, Wei X, Mei P, Wang X, Zhang C, Huang Q, Liao Y. Meng Y, et al. Cancer Lett. 2024 Feb 1;582:216587. doi: 10.1016/j.canlet.2023.216587. Epub 2023 Dec 13. Cancer Lett. 2024. PMID: 38097136

4

Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer.

Lin W, Wang X, Diao M, Wang Y, Zhao R, Chen J, Liao Y, Long Q, Meng Y. Lin W, et al. Among authors: meng y. Cancer Cell Int. 2024 Jul 9;24(1):239. doi: 10.1186/s12935-024-03418-x. Cancer Cell Int. 2024. PMID: 38982494 Free PMC article. Review.

5

Diagnostic Value of GDF10 for the Tumorigenesis and Immune Infiltration in Lung Squamous Cell Carcinoma.

Wang XJ, Chen JP, Qiao XW, Meng WY, Wang YW, Meng YC, Zhao R, Lin W, Liao YD, Xiao H, Mei PY. Wang XJ, et al. Curr Med Sci. 2024 Apr;44(2):309-327. doi: 10.1007/s11596-023-2806-6. Epub 2024 Mar 22. Curr Med Sci. 2024. PMID: 38517673

6

Upregulation of estrogen receptor beta protein but not mRNA predicts poor prognosis and may be associated with enhanced translation in non-small cell lung cancer: a systematic review and meta-analysis.

Meng W, Liao Y, Chen J, Wang Y, Meng Y, Li K, Xiao H. Meng W, et al. Among authors: meng y. J Thorac Dis. 2021 Jul;13(7):4281-4300. doi: 10.21037/jtd-21-658. J Thorac Dis. 2021. PMID: 34422356 Free PMC article.

7

The Prognostic Value of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma.

Meng W, Xiao H, Zhao R, Li D, Li K, Meng Y, Chen J, Wang Y, Liao Y. Meng W, et al. Among authors: meng y. Front Oncol. 2021 Oct 22;11:608239. doi: 10.3389/fonc.2021.608239. eCollection 2021. Front Oncol. 2021. PMID: 34745928 Free PMC article.

8

Minimally invasive esophagectomy with intrathoracic anastomosis in a situs inversus totalis patient.

Meng Y, Xiao H, Zhang Z, Li K, Huang Q, Qiu W, Liao Y. Meng Y, et al. J Surg Case Rep. 2020 Nov 27;2020(11):rjaa480. doi: 10.1093/jscr/rjaa480. eCollection 2020 Nov. J Surg Case Rep. 2020. PMID: 33274044 Free PMC article.

9

Efficacy and safety of chimeric antigen receptor T cell immunotherapy in B-cell non-Hodgkin lymphoma: a systematic review and meta-analysis.

Wang N, Meng Y, Wu Y, He J, Liu F. Wang N, et al. Among authors: meng y. Immunotherapy. 2021 Mar;13(4):345-357. doi: 10.2217/imt-2020-0221. Epub 2021 Jan 7. Immunotherapy. 2021. PMID: 33406914

10

TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway.

Wei X, Lou H, Zhou D, Jia Y, Li H, Huang Q, Ma J, Yang Z, Sun C, Meng Y, Xu S, Yang X, Li X, Ji T, Guo Z, Gao Q. Wei X, et al. Among authors: meng y. J Exp Clin Cancer Res. 2021 Sep 19;40(1):292. doi: 10.1186/s13046-021-02091-6. J Exp Clin Cancer Res. 2021. PMID: 34538264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,103 results

Search Page

Filters